{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:46:46Z","timestamp":1745419606159},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00108-017-0357-2","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T15:18:31Z","timestamp":1511795911000},"page":"114-124","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolische Entgleisungen als paraneoplastische Syndrome"],"prefix":"10.1007","volume":"59","author":[{"given":"S.","family":"Krug","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Michl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"key":"357_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1742-1241.2005.00623.x","volume":"60","author":"S Agnani","year":"2006","unstructured":"Agnani S, Gupta R, Atray NK et\u00a0al (2006) Marked hyperuricemia with acute renal failure: need to consider occult malignancy and spontaneous tumour lysis syndrome. Int J Clin Pract 60:364\u2013366","journal-title":"Int J Clin Pract"},{"key":"357_CR2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1210\/jcem-1-9-711","volume":"1","author":"F Albright","year":"1941","unstructured":"Albright F, Burnett CH, Cope O, Parson W (1941) Acute atrophy of bone (osteoporosis) simulating hyperthyreodism12. J\u00a0Clin Endocrinol 1:711\u2013716","journal-title":"J Clin Endocrinol"},{"key":"357_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198101293040505","volume":"304","author":"LA Austin","year":"1981","unstructured":"Austin LA, Heath H (1981) Calcitonin: physiology and pathophysiology. N\u00a0Engl J Med 304:269\u2013278","journal-title":"N Engl J Med"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcms.2013.11.011","volume":"42","author":"Y A\u00e7\u0131kg\u00f6z","year":"2014","unstructured":"A\u00e7\u0131kg\u00f6z Y, Sendur MA, Ozdemir NY et\u00a0al (2014) Longest survival of lung metastatic ameloblastoma with a\u00a0rare cause of malignant hypercalcemia. J\u00a0Craniomaxillofac Surg 42:277\u2013278","journal-title":"J Craniomaxillofac Surg"},{"key":"357_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00405-005-0942-1","volume":"263","author":"LW Baijens","year":"2006","unstructured":"Baijens LW, Manni JJ (2006) Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a\u00a0review of the literature. Eur Arch Otorhinolaryngol 263:32\u201336","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"357_CR6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-156-12-201206190-00026","volume":"156","author":"A Bech","year":"2012","unstructured":"Bech A, de Boer H (2012) Denosumab for tumor-induced hypercalcemia complicated by renal failure. Ann Intern Med 156:906\u2013907","journal-title":"Ann Intern Med"},{"key":"357_CR7","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL et\u00a0al (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N\u00a0Engl J Med 353:2450\u20132461","journal-title":"N Engl J Med"},{"key":"357_CR8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, MacDonald PA et\u00a0al (2009) Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J\u00a0Rheumatol 36:1273\u20131282","journal-title":"J Rheumatol"},{"key":"357_CR9","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","volume":"47","author":"Q Ben","year":"2011","unstructured":"Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928\u20131937","journal-title":"Eur J Cancer"},{"key":"357_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4158\/EP12166.RA","volume":"18","author":"JP Bilezikian","year":"2012","unstructured":"Bilezikian JP (2012) Primary hyperparathyroidism. Endocr Pract 18:781\u2013790","journal-title":"Endocr Pract"},{"key":"357_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.0954-6820.1986.tb02745.x","volume":"220","author":"CP Blomqvist","year":"1986","unstructured":"Blomqvist CP (1986) A hospital survey of hypocalcemia in patients with malignant disease. Acta Med Scand 220:167\u2013173","journal-title":"Acta Med Scand"},{"key":"357_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3\u201311","journal-title":"Br J Haematol"},{"key":"357_CR13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","volume":"149","author":"MS Cairo","year":"2010","unstructured":"Cairo MS, Coiffier B, Reiter A et\u00a0al (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149:578\u2013586","journal-title":"Br J Haematol"},{"key":"357_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clml.2016.11.003","volume":"17","author":"MS Cairo","year":"2017","unstructured":"Cairo MS, Thompson S, Tangirala K et\u00a0al (2017) A clinical and economic comparison of Rasburicase and Allopurinol in the treatment of patients with clinical or laboratory tumor lysis\u00a0syndrome. Clin Lymphoma Myeloma Leuk 17:173\u2013178","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"357_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13256-017-1241-3","volume":"11","author":"VE Catania","year":"2017","unstructured":"Catania VE, Vecchio M, Malaguarnera M et\u00a0al (2017) Tumor lysis syndrome in an extraskeletal osteosarcoma: a\u00a0case report and review of the literature. J\u00a0Med Case Rep 11:79","journal-title":"J Med Case Rep"},{"key":"357_CR16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari ST, Leibson CL, Rabe KG et al (2005) Probability of pancreatic cancer following diabetes: a\u00a0population-based study. Gastroenterology 129:504\u2013511","journal-title":"Gastroenterology"},{"key":"357_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-017-0701-0","volume":"16","author":"K Chen","year":"2017","unstructured":"Chen K, Qian W, Jiang Z et\u00a0al (2017) Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol Cancer 16:131","journal-title":"Mol Cancer"},{"key":"357_CR18","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.clml.2014.07.005","volume":"14","author":"JD Cicci","year":"2014","unstructured":"Cicci JD, Buie L, Bates J et\u00a0al (2014) Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction. Clin Lymphoma Myeloma Leuk 14:e207\u2013e211","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"357_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/erc.1.00543","volume":"12","author":"GA Clines","year":"2005","unstructured":"Clines GA, Guise TA (2005) Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12:549\u2013583","journal-title":"Endocr Relat Cancer"},{"key":"357_CR20","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J\u00a0Clin Oncol 26:2767\u20132778","journal-title":"J Clin Oncol"},{"key":"357_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1752-1947-5-318","volume":"5","author":"K Coners","year":"2011","unstructured":"Coners K, Woods SE, Webb M (2011) Dual paraneoplastic syndromes in a\u00a0patient with small cell lung cancer: a\u00a0case report. J\u00a0Med Case Rep 5:318","journal-title":"J Med Case Rep"},{"key":"357_CR22","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1200\/JCO.2009.26.8896","volume":"28","author":"J Cortes","year":"2010","unstructured":"Cortes J, Moore JO, Maziarz RT et\u00a0al (2010) Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone \u2013 results of a\u00a0multicenter phase III study. J\u00a0Clin Oncol 28:4207\u20134213","journal-title":"J Clin Oncol"},{"key":"357_CR23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.14310\/horm.2002.1447","volume":"12","author":"G Cvijovic","year":"2013","unstructured":"Cvijovic G, Micic D, Kendereski A et\u00a0al (2013) Ectopic calcitonin secretion in a\u00a0woman with large cell neuroendocrine lung carcinoma. Hormones (Athens) 12:584\u2013590","journal-title":"Hormones (Athens)"},{"key":"357_CR24","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1200\/JCO.2010.32.6751","volume":"29","author":"M Darmon","year":"2011","unstructured":"Darmon M, Guichard I, Vincent F (2011) Rasburicase and tumor lysis syndrome: lower dosage, consideration of indications, and hyperhydration. J\u00a0Clin Oncol 29:e67\u2013e68 (author reply e69)","journal-title":"J Clin Oncol"},{"key":"357_CR25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12415","volume":"162","author":"M Darmon","year":"2013","unstructured":"Darmon M, Vincent F, Camous L et al (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en R\u00e9animation Respiratoire et Onco-H\u00e9matologique. Br J Haematol 162:489\u2013497","journal-title":"Br J Haematol"},{"key":"357_CR26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","volume":"116","author":"MB Davidson","year":"2004","unstructured":"Davidson MB, Thakkar S, Hix JK et\u00a0al (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116:546\u2013554","journal-title":"Am J Med"},{"key":"357_CR27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/pgmj.63.743.745","volume":"63","author":"DM Dent","year":"1987","unstructured":"Dent DM, Miller JL, Klaff L et\u00a0al (1987) The incidence and causes of hypercalcaemia. Postgrad Med\u00a0J 63:745\u2013750","journal-title":"Postgrad Med J"},{"key":"357_CR28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejca.2015.04.017","volume":"51","author":"IJ Diel","year":"2015","unstructured":"Diel IJ, Body JJ, Stopeck AT et\u00a0al (2015) The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. Eur J Cancer 51:1467\u20131475","journal-title":"Eur J Cancer"},{"key":"357_CR29","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0147","author":"U Durani","year":"2017","unstructured":"Durani U, Shah ND, Go RS (2017) In-hospital outcomes of tumor lysis syndrome: a population-based study using the national inpatient sample. Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2017-0147","journal-title":"Oncologist"},{"key":"357_CR30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bone.2006.11.009","volume":"40","author":"GG Eynden Van den","year":"2007","unstructured":"Van den Eynden GG, Neyret A, Fumey G et\u00a0al (2007) PTHrP, calcitonin and calcitriol in a\u00a0case of severe, protracted and refractory hypercalcemia due to a\u00a0pancreatic neuroendocrine tumor. Bone 40:1166\u20131171","journal-title":"Bone"},{"key":"357_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14740\/wjon953w","volume":"7","author":"RJ Galindo","year":"2016","unstructured":"Galindo RJ, Romao I, Valsamis A et\u00a0al (2016) Hypercalcemia of malignancy and colorectal cancer. World J Oncol 7:5\u201312","journal-title":"World J Oncol"},{"key":"357_CR32","doi-asserted-by":"crossref","first-page":"e7417","DOI":"10.1097\/MD.0000000000007417","volume":"96","author":"G Han","year":"2017","unstructured":"Han G, Zhang Z, Shen X et al (2017) Doege-potter syndrome: a review of the literature including a\u00a0new case report. Medicine (Baltimore) 96:e7417","journal-title":"Medicine (Baltimore)"},{"key":"357_CR33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"DA Hanley","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A et\u00a0al (2012) Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract 66:1139\u20131146","journal-title":"Int J Clin Pract"},{"key":"357_CR34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","volume":"166","author":"Y Hong","year":"2012","unstructured":"Hong Y, Hay DL, Quirion R et\u00a0al (2012) The pharmacology of adrenomedullin 2\/intermedin. Br J Pharmacol 166:110\u2013120","journal-title":"Br J Pharmacol"},{"key":"357_CR35","first-page":"473","volume":"50","author":"DJ Hosking","year":"1981","unstructured":"Hosking DJ, Cowley A, Bucknall CA (1981) Rehydration in the treatment of severe hypercalcaemia. Q\u00a0J Med 50:473\u2013481","journal-title":"Q J Med"},{"key":"357_CR36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N\u00a0Engl J Med 364:1844\u20131854","journal-title":"N Engl J Med"},{"key":"357_CR37","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2014-1001","volume":"99","author":"MI Hu","year":"2014","unstructured":"Hu MI, Glezerman IG, Leboulleux S et\u00a0al (2014) Denosumab for treatment of hypercalcemia of malignancy. J\u00a0Clin Endocrinol Metab 99:3144\u20133152","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/pgmj.71.831.28","volume":"71","author":"AC Hutchesson","year":"1995","unstructured":"Hutchesson AC, Bundred NJ, Ratcliffe WA (1995) Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med\u00a0J 71:28\u201331","journal-title":"Postgrad Med J"},{"key":"357_CR39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington de Gonz\u00e1lez A et al (2005) Type-II diabetes and pancreatic cancer: a\u00a0meta-analysis of 36 studies. Br J Cancer 92:2076\u20132083","journal-title":"Br J Cancer"},{"key":"357_CR40","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-13-1012","volume":"170","author":"P Iglesias","year":"2014","unstructured":"Iglesias P, D\u00edez JJ (2014) Management of endocrine disease: a\u00a0clinical update on tumor-induced hypoglycemia. Eur J Endocrinol 170:R147\u2013R157","journal-title":"Eur J Endocrinol"},{"key":"357_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.05.044","author":"M Ignaszewski","year":"2017","unstructured":"Ignaszewski M, Kohlitz P (2017) Treatment-na\u00efve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: an unusual suspect. Am J Emerg Med. https:\/\/doi.org\/10.1016\/j.ajem.2017.05.044","journal-title":"Am J Emerg Med"},{"key":"357_CR42","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1677\/ERC-10-0024","volume":"17","author":"G Kaltsas","year":"2010","unstructured":"Kaltsas G, Androulakis II, de Herder WW et\u00a0al (2010) Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer 17:R173\u2013R193","journal-title":"Endocr Relat Cancer"},{"key":"357_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5731417","author":"SW Kim","year":"2016","unstructured":"Kim SW, Lee SE, Oh YL et\u00a0al (2016) Nonislet cell tumor hypoglycemia in a\u00a0patient with adrenal cortical carcinoma. Case Rep Endocrinol. https:\/\/doi.org\/10.1155\/2016\/5731417","journal-title":"Case Rep Endocrinol"},{"key":"357_CR44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/bjc.2016.277","volume":"115","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Costello E, Jackson R et\u00a0al (2016) The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. Br J Cancer 115:887\u2013894","journal-title":"Br J Cancer"},{"key":"357_CR45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/qjmed\/hcr249","volume":"107","author":"TI Korevaar","year":"2014","unstructured":"Korevaar TI, Ragazzoni F, Weaver A et al (2014) IGF2-induced hypoglycemia unresponsive to everolimus. QJM 107:297\u2013300","journal-title":"QJM"},{"key":"357_CR46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jcem-48-3-393","volume":"48","author":"JH Ladenson","year":"1979","unstructured":"Ladenson JH, Lewis JW, McDonald JM et\u00a0al (1979) Relationship of free and total calcium in hypercalcemic conditions. J\u00a0Clin Endocrinol Metab 48:393\u2013397","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"357_CR47","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/jbmr.5650061413","volume":"6","author":"FW Lafferty","year":"1991","unstructured":"Lafferty FW (1991) Differential diagnosis of hypercalcemia. J\u00a0Bone Miner Res 6(Suppl 2):S51\u2013S59. https:\/\/doi.org\/10.1002\/jbmr.5650061413 (discussion S61)","journal-title":"J Bone Miner Res"},{"key":"357_CR48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","volume":"149","author":"SB LeGrand","year":"2008","unstructured":"LeGrand SB, Leskuski D, Zama I (2008) Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 149:259\u2013263","journal-title":"Ann Intern Med"},{"key":"357_CR49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bjc.1995.304","volume":"72","author":"PJ Ling","year":"1995","unstructured":"Ling PJ, A\u2019Hern RP, Hardy JR (1995) Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). Br J Cancer 72:206\u2013209","journal-title":"Br J Cancer"},{"key":"357_CR50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2013.02.378","volume":"62","author":"MA Lopez-Olivo","year":"2013","unstructured":"Lopez-Olivo MA, Pratt G, Palla SL et al (2013) Rasburicase in tumor lysis syndrome of the adult: a\u00a0systematic review and meta-analysis. Am J Kidney Dis 62:481\u2013492","journal-title":"Am J Kidney Dis"},{"key":"357_CR51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","volume":"19","author":"P Major","year":"2001","unstructured":"Major P, Lortholary A, Hon J et\u00a0al (2001) Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a\u00a0pooled analysis of two randomized, controlled clinical trials. J\u00a0Clin Oncol 19:558\u2013567","journal-title":"J Clin Oncol"},{"key":"357_CR52","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.2005.01.069","volume":"23","author":"S Mayer","year":"2005","unstructured":"Mayer S, Cypess AM, Kocher ON et al (2005) Uncommon presentations of some common malignancies: case 1. Sequential paraneoplastic endocrine syndromes in small-cell lung cancer. J\u00a0Clin Oncol 23:1312\u20131314","journal-title":"J Clin Oncol"},{"key":"357_CR53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4103\/1947-2714.170600","volume":"7","author":"AE Mirrakhimov","year":"2015","unstructured":"Mirrakhimov AE (2015) Hypercalcemia of malignancy: an update on pathogenesis and management. N\u00a0Am J Med Sci 7:483\u2013493","journal-title":"N Am J Med Sci"},{"key":"357_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.11575","volume":"93","author":"P Montesinos","year":"2008","unstructured":"Montesinos P, Lorenzo I, Mart\u00edn G et\u00a0al (2008) Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a\u00a0predictive model. Haematologica 93:67\u201374","journal-title":"Haematologica"},{"key":"357_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clcc.2014.06.006","volume":"13","author":"N Ngo","year":"2014","unstructured":"Ngo N, Edriss H, Figueroa JA et\u00a0al (2014) Squamous cell carcinoma of the sigmoid colon presenting with severe hypercalcemia. Clin Colorectal Cancer 13:251\u2013254","journal-title":"Clin Colorectal Cancer"},{"key":"357_CR56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1530\/EC-16-0043","volume":"5","author":"K Oberg","year":"2016","unstructured":"Oberg K, Krenning E, Sundin A et\u00a0al (2016) A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect 5:174\u2013187","journal-title":"Endocr Connect"},{"key":"357_CR57","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1210\/jc.2014-4534","volume":"100","author":"S Otake","year":"2015","unstructured":"Otake S, Kikkawa T, Takizawa M et al (2015) Hypoglycemia observed on continuous glucose monitoring associated with IGF-2-producing solitary fibrous tumor. J\u00a0Clin Endocrinol Metab 100:2519\u20132524","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala R, Leirness JB, Bamlet WR et al (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134:981\u2013987","journal-title":"Gastroenterology"},{"key":"357_CR59","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00520-003-0477-1","volume":"11","author":"M Pecherstorfer","year":"2003","unstructured":"Pecherstorfer M, Steinhauer EU, Rizzoli R et\u00a0al (2003) Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a\u00a0randomized multicentric comparison to pamidronate. Support Care Cancer 11:539\u2013547","journal-title":"Support Care Cancer"},{"key":"357_CR60","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1572-0241.2007.01480.x","volume":"102","author":"M Pelaez-Luna","year":"2007","unstructured":"Pelaez-Luna M, Takahashi N, Fletcher JG et al (2007) Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a\u00a0retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 102:2157\u20132163","journal-title":"Am J Gastroenterol"},{"key":"357_CR61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2796.1989.tb01423.x","volume":"226","author":"JA Riancho","year":"1989","unstructured":"Riancho JA, Arjona R, Valle R et\u00a0al (1989) The clinical spectrum of hypocalcaemia associated with bone metastases. J\u00a0Intern Med 226:449\u2013452","journal-title":"J Intern Med"},{"key":"357_CR62","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jnci\/djs208","volume":"104","author":"G Rindi","year":"2012","unstructured":"Rindi G, Falconi M, Klersy C et\u00a0al (2012) TNM staging of neoplasms of the endocrine pancreas: results from a\u00a0large international cohort study. J\u00a0Natl Cancer Inst 104:764\u2013777","journal-title":"J Natl Cancer Inst"},{"key":"357_CR63","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347","journal-title":"Ann Oncol"},{"key":"357_CR64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","volume":"10","author":"RP Sah","year":"2013","unstructured":"Sah RP, Nagpal SJ, Mukhopadhyay D et al (2013) New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol 10:423\u2013433","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"357_CR65","first-page":"1679","volume":"9","author":"H Shen","year":"2016","unstructured":"Shen H, Zhan M, Wang W et al (2016) Impact of diabetes mellitus on the survival of pancreatic cancer: a\u00a0meta-analysis. Onco Targets Ther 9:1679\u20131688","journal-title":"Onco Targets Ther"},{"key":"357_CR66","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4158\/EP.15.3.234","volume":"15","author":"SB Shivnani","year":"2009","unstructured":"Shivnani SB, Shelton JM, Richardson JA et al (2009) Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone \u2013 related peptide and 1,25-dihydroxyvitamin D in a\u00a0patient with metastatic renal cell carcinoma. Endocr Pract 15:234\u2013239","journal-title":"Endocr Pract"},{"key":"357_CR67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00520-012-1683-5","volume":"21","author":"MS Soyfoo","year":"2013","unstructured":"Soyfoo MS, Brenner K, Paesmans M et al (2013) Non-malignant causes of hypercalcemia in cancer patients: a\u00a0frequent and neglected occurrence. Support Care Cancer 21:1415\u20131419","journal-title":"Support Care Cancer"},{"key":"357_CR68","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/annonc\/mdv317","volume":"26","author":"M Spina","year":"2015","unstructured":"Spina M, Nagy Z, Ribera JM et al (2015) FLORENCE: a\u00a0randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Ann Oncol 26:2155\u20132161","journal-title":"Ann Oncol"},{"key":"357_CR69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N\u00a0Engl J Med 352:373\u2013379","journal-title":"N Engl J Med"},{"key":"357_CR70","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10147-016-0971-3","volume":"21","author":"K Tamura","year":"2016","unstructured":"Tamura K, Kawai Y, Kiguchi T et al (2016) Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a\u00a0phase III, randomized, multi-center trial comparing febuxostat and allopurinol. Int J Clin Oncol 21:996\u20131003","journal-title":"Int J Clin Oncol"},{"key":"357_CR71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2265.2004.01989.x","volume":"60","author":"JD Teale","year":"2004","unstructured":"Teale JD, Wark G (2004) The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) 60:457\u2013460","journal-title":"Clin Endocrinol (Oxf)"},{"key":"357_CR72","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3324\/haematol.13290","volume":"93","author":"P Tosi","year":"2008","unstructured":"Tosi P, Barosi G, Lazzaro C et\u00a0al (2008) Consensus conference on the management of tumor lysis syndrome. Haematologica 93:1877\u20131885","journal-title":"Haematologica"},{"key":"357_CR73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ncpneph0248","volume":"2","author":"H Trimarchi","year":"2006","unstructured":"Trimarchi H, Lombi F, Forrester M et\u00a0al (2006) Disodium pamidronate for treating severe hypercalcemia in a\u00a0hemodialysis patient. Nat Clin Pract Nephrol 2:459\u2013463 (quiz 464)","journal-title":"Nat Clin Pract Nephrol"},{"key":"357_CR74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tem.2012.10.006","volume":"24","author":"M Tsoli","year":"2013","unstructured":"Tsoli M, Robertson G (2013) Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol Metab 24:174\u2013183","journal-title":"Trends Endocrinol Metab"},{"key":"357_CR75","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jc.2005-2095","volume":"91","author":"JN VanHouten","year":"2006","unstructured":"VanHouten JN, Yu N, Rimm D et\u00a0al (2006) Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J\u00a0Clin Endocrinol Metab 91:580\u2013583","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR76","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M","volume":"71","author":"R Vassilopoulou-Sellin","year":"1993","unstructured":"Vassilopoulou-Sellin R, Newman BM, Taylor SH et al (1993) Incidence of hypercalcemia in patients with malignancy referred to a\u00a0comprehensive cancer center. Cancer 71:1309\u20131312","journal-title":"Cancer"},{"key":"357_CR77","first-page":"1169","volume":"11","author":"S Wada","year":"2001","unstructured":"Wada S, Yasuda S (2001) Appropriate clinical usage of calcitonin escape phenomenon and intermittent v.s. daily administration of calcitonin. Clin Calcium 11:1169\u20131175","journal-title":"Clin Calcium"},{"issue":"Suppl 1","key":"357_CR78","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1007\/BF02553290","volume":"46","author":"LA Wisneski","year":"1990","unstructured":"Wisneski LA (1990) Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int 46(Suppl 1):S26\u2013S30. https:\/\/doi.org\/10.1007\/BF02553290","journal-title":"Calcif Tissue Int"},{"key":"357_CR79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","volume":"82","author":"W W\u00f6ssmann","year":"2003","unstructured":"W\u00f6ssmann W, Schrappe M, Meyer U et\u00a0al (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkitt\u2019s lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 82:160\u2013165","journal-title":"Ann Hematol"},{"key":"357_CR80","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/07357907.2015.1047506","volume":"33","author":"JD Wright","year":"2015","unstructured":"Wright JD, Tergas AI, Ananth CV et\u00a0al (2015) Quality and outcomes of treatment of hypercalcemia of malignancy. Cancer Invest 33:331\u2013339","journal-title":"Cancer Invest"},{"key":"357_CR81","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cncr.28506","volume":"120","author":"Y Yamada","year":"2014","unstructured":"Yamada Y, Kohashi K, Fushimi F et al (2014) Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Cancer 120:864\u2013876","journal-title":"Cancer"},{"key":"357_CR82","doi-asserted-by":"crossref","first-page":"25242","DOI":"10.18632\/oncotarget.15692","volume":"8","author":"PT Zhou","year":"2017","unstructured":"Zhou PT, Li B, Liu FR et al (2017) Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a\u00a0systematic review and meta-analysis. Oncotarget 8:25242\u201325250","journal-title":"Oncotarget"},{"key":"357_CR83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-0115(03)00030-2","volume":"112","author":"E Zudaire","year":"2003","unstructured":"Zudaire E, Cuttitta F, Mart\u00ednez A (2003) Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regul Pept 112:121\u2013130","journal-title":"Regul Pept"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0357-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0357-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0357-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T22:43:24Z","timestamp":1603406604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0357-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0357-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}